This study analyzed the interaction of adolescent methylphenidate on the behavioral response to nicotine and the effects of these drug treatments on brain-derived neurotrophic factor in the nucleus accumbens and hippocampus in male and female Sprague-Dawley rats. Animals were intraperitoneal administered 1 mg/kg methylphenidate or saline using a “school day” regimen (five days on, two days off) beginning on postnatal day (P)28 and throughout behavioral testing. In Experiment 1, animals were intraperitoneal administered 0.5 mg/kg (free base) nicotine or saline every second day for 10 days from P45–P63 and tested after a three-day drug washout on the forced swim stress task on P67–P68. Results revealed that adolescent methylphenidate blunted nicotine behavioral sensitization. However, methylphenidate-treated rats given saline during sensitization demonstrated decreased latency to immobility and increased immobility time on the forced swim stress task in males that was reduced by nicotine. In Experiment 2, a different set of animals were conditioned to nicotine (0.6 mg/kg free base) or saline using the conditioned place preference behavioral paradigm from P44–P51, and given a preference test on P52. On P53, the nucleus accumbens and hippocampus were analyzed for brain-derived neurotrophic factor. Methylphenidate enhanced nicotine-conditioned place preference in females and nicotine produced conditioned place preference in males and females pre-exposed to saline in adolescence. In addition, methylphenidate and nicotine increased nucleus accumbens brain-derived neurotrophic factor in females and methylphenidate enhanced hippocampus brain-derived neurotrophic factor in males and females. Methylphenidate adolescent exposure using a clinically relevant dose and regimen results in changes in the behavioral and brain-derived neurotrophic factor responses to nicotine in adolescence that are sex-dependent.
AndersenSLTeicherMH (2000) Sex differences in dopamine receptors and the relevance to ADHD. Neurosci Biobehav Rev24: 137–141.
2.
ArndtDLPetersonCJCainME (2015) Differential rearing alters forced swim test behavior, fluoxetine efficacy, and post-test weight gain in male rats. PLoS One10: e0131709.
3.
BeckerJB (1999) Gender differences in dopaminergic function in striatum and nucleus accumbens. Pharmacol Biochem Behav64: 803–812.
4.
BenowitzNLPorchetHSheinerL. (1988) Nicotine absorption and cardiovascular effects with smokeless tobacco use: Comparison with cigarettes and nicotine gum. Clin Pharmacol Ther44: 23–28.
5.
BerridgeCWDevilbissDMAndrzejewskiME. (2006) Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function. Biol Psychiatry60: 1111–1120.
6.
BialaGPekalaKBoguszewska-CzubaraA. (2016) Behavioral and biochemical interaction between nicotine and chronic unpredictable mild stress in mice. Mol Neurobiol. Epub ahead of print 18January2016. DOI: 10.1007/s12035-016-9701-0.
7.
BiedermanJ (2008) Effect of prior stimulant treatment for attention-deficit/hyperactivity disorder on subsequent risk for cigarette smoking and alcohol and drug use disorders in adolescents. Arch Pediatr Adolesc Med162: 916–921.
8.
BogdanovaOVKanekarSD’AnciKE. (2013) Factors influencing behavior in the forced swim test. Physiol Behav118: 227–239.
9.
BolañosCANestlerEJ (2004) Neurotrophic mechanisms in drug addiction. Neuromol Med5: 69–83.
10.
BorsoiMAntonioCBMüllerLG. (2015) Repeated forced swimming impairs prepulse inhibition and alters brain-derived neurotrophic factor and astroglial parameters in rats. Pharmacol Biochem Behav128: 50–61.
11.
BrandNGeenenROudenhovenM. (2002) Brief report: Cognitive functioning in children with Tourette’s syndrome with and without comorbid ADHD. J Pediatr Psychol27: 203–208.
12.
BrandonCLMarinelliMBakerLK. (2001) Enhanced reactivity and vulnerability to cocaine following methylphenidate treatment in adolescent rats. Neuropsychopharmacology25: 651–661.
13.
BriandLABlendyJA (2010) Molecular and genetic substrates linking stress and addiction. Brain Res1314: 219–234.
14.
BrownRWHughesBAHughesAB. (2012) Sex and dose-related differences in methylphenidate adolescent locomotor sensitization and effects on brain-derived neurotrophic factor. J Psychopharmacol26: 1480–1488.
15.
CarlezonWAMagueSDAndersenSL (2003) Enduring behavioral effects of early exposure to methylphenidate in rats. Biol Psychiatry54: 1330–1337.
16.
ChongSLClaussenCMDafnyN (2012) Nucleus accumbens neuronal activity in freely behaving rats is modulated following acute and chronic methylphenidate administration. Brain Res Bull87: 445–456.
17.
CrawfordCAVillafrancaSWCyrMC. SA (2007) Effects of early methylphenidate exposure on morphine- and sucrose-reinforced behaviors in adult rats: Relationship to dopamine D2 receptors. Brain Res1139: 245–253.
18.
CumminsEDGriffinSBDutyCM. (2014) The role of dopamine D1 and D2 receptors in adolescent methylphenidate conditioned place preference: Sex differences and brain-derived neurotrophic factor. Dev Neurosci36: 277–286.
19.
CzubakANowakowskaEKusK. (2009) Influences of chronic venlafaxine, olanzapine and nicotine on the hippocampal and cortical concentrations of brain-derived neurotrophic factor (BDNF). Pharmacol Rep61: 1017–1023.
20.
De la PeñaJBAhsanHMTampusR. (2015) Cigarette smoke exposure during adolescence enhances sensitivity to the rewarding effects of nicotine in adulthood, even after a long period of abstinence. Neuropharmacology99: 9–14.
21.
Di ChiaraG (2000) Role of dopamine in the behavioural actions of nicotine related to addiction. Eur J Pharm393: 295–314.
22.
DumanRS. (2014) Pathophysiology of depression and innovative treatments: Remodeling glutamatergic synaptic connections. Dialogues Clin Neurosci16: 11–27.
23.
FumagalliFCattaneoACaffinoL. (2010) Sub-chronic exposure to atomoxetine up-regulates BDNF expression and signalling in the brain of adolescent spontaneously hypertensive rats: Comparison with methylphenidate. Pharmacol Res62: 523–529.
24.
GerasimovMRFranceschiMVolkowND. (2000) Synergistic interactions between nicotine and cocaine or methylphenidate depend on the dose of dopamine transporter inhibitor. Synapse38: 432–437.
25.
GhitzaUEZhaiHWuP. (2010) Role of BDNF and GDNF in drug reward and relapse: A review. Neurosci Biobehav Rev35: 157–171.
26.
HollingsworthEMMuellerK (1988) Patterns of locomotor and stereotypic behavior during continuous amphetamine administration in rats. Pharmacol Biochem Behav30: 535–537.
27.
KandelDBChenK (2000) Extent of smoking and nicotine dependence in the United States: 1991–1993. Nicotine Tob Res2: 263–274.
28.
KennyPJFileSERattrayM (2000) Acute nicotine decreases, and chronic nicotine Increases the expression of brain-derived neurotrophic factor mRNA in rat hippocampus. Mol Brain Res85: 234–238.
29.
KimHHeoHIKimDH. (2011) Treadmill exercise and methylphenidate ameliorate symptoms of attention deficit/hyperactivity disorder through enhancing dopamine synthesis and brain-derived neurotrophic factor expression in spontaneous hypertensive rats. Neurosci Lett504: 35–39.
30.
KoobGFLe MoalM (2008) Neurobiological mechanisms for opponent motivational processes in addiction. Philos Trans R Soc Lond B Biol Sci363: 3113–3123.
31.
KuczenskiRSegalDS (2002) Exposure of adolescent rats to oral methylphenidate: Preferential effects on extracellular norepinephrine and absence of sensitization and cross-sensitization to methamphetamine. J Neurosci200222: 7264–7271.
32.
KuczenskiRSegalDS (2005) Stimulant actions in rodents: Implications for attention-deficit/hyperactivity disorder treatment and potential substance abuse. Biol Psychiatry57: 1391–1396.
33.
LakhanSEKirchgessnerA (2012) Prescription stimulants in individuals with and without attention deficit hyperactivity disorder: Misuse, cognitive impact, and adverse effects. Brain Behav2: 661–677.
34.
LenoirMStarosciakAKLedonJ. (2015) Sex differences in conditioned nicotine reward are age-specific. Pharmacol Biochem Behav132: 56–62.
35.
MojicaCYBelluzziJDLeslieFM (2014) Age-dependent alterations in reward-seeking behavior after brief nicotine exposure. Psychopharmacology231: 1763–1773.
36.
MosaferiBBabriSMohaddesG. (2015) Post-weaning environmental enrichment improves BDNF response of adult male rats. Int J Dev Neurosci46: 108–114.
37.
MotaghinejadMMotevalianMLarijaniSF. (2015) Protective effects of forced exercise against methylphenidate-induced anxiety, depression and cognition impairment in rat. Adv Biomed Res4: 134.
38.
National Research council (2011) NIH Guide for the Care and Use of Laboratory Animals. 8th edition. Washington, DC: National Academies Press.
39.
PernaMKBrownW (2013) Adolescent nicotine sensitization and effects of nicotine on accumbal dopamine release in a rodent model of increased dopamine D2 receptor sensitivity. Behav Brain Res242: 102–109.
40.
PickensCLAiravaaraMThebergeF. (2011) Neurobiology of the incubation of drug craving. Trends Neurosci34: 411–420.
41.
PierceRCKalivasPW (1997) A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res Brain Res Rev25: 192–216.
42.
RowlandASLesesneCAAbramowitzAJ (2002) The epidemiology of attention- deficit/hyperactivity disorder (ADHD): A public health view. Ment Retard Dev Disabil Res Rev8: 162–170.
SchassburgerRLPitzerEMSmithTT. (2016) Adolescent rats self-administer less nicotine than adults at low doses. Nicotine Tob Res13: 1861–1868.
45.
SchererEBda CunhaMJMattéC. (2010) Methylphenidate affects memory, brain-derived neurotrophic factor immunocontent and brain acetylcholinesterase activity in the rat. Neurobio Learn Mem94: 247–253.
46.
SchweriMMSkolnickPRaffertyMF. (1985) [3H] Threo-(±)-methylphenidate binding to 3, 4-dihydroxyphenylethylamine uptake sites in corpus striatum: Correlation with the stimulant properties of ritalinic acid esters. J Neurochem45: 1062–1070.
47.
ShramMJFunkDLiZ. (2006) Periadolescent and adult rats respond differently in tests measuring the rewarding and aversive effects of nicotine. Psychopharmacology186: 201–208.
48.
SlaweckiCJThorsellAKEl KhouryA. (2005) Increased CRF-like and NPY-like immunoreactivity in adult rats exposed to nicotine during adolescence: Relation to anxiety-like and depressive-like behavior. Neuropeptides39: 369–377.
49.
TaioliEWynderEL (1991) Effect of the age at which smoking begins on frequency of smoking in adulthood. N Engl J Med325: 968–969.
50.
ThanosPDelisFRoskoL. (2013) Passive response to stress in adolescent female and adult male mice after intermittent nicotine exposure in adolescence. J Addict Res Ther Suppl6: 007.
51.
ThaiDLYurasitsLNRudolphGR. (1999) Comparative pharmacokinetics and tissue distribution of the d-enantiomers of para-substituted methylphenidate analogs. Drug Metab Dispos27: 645–650.
52.
UrbanKRGaoWJ (2013) Methylphenidate and the juvenile brain: Enhancement of attention at the expense of cortical plasticity?Med Hypotheses81: 988–994.
53.
VansickelARStoopsWWGlaserPE. (2011) Methylphenidate increases cigarette smoking in participants with ADHD. Psychopharmacology218: 381–390.
54.
VastolaBJDouglasLAVarlinskayaEI. (2002) Nicotine-induced conditioned place preference in adolescent and adult rats. Physiol Behav77: 107–114.
55.
VolkowNWangGFowlerJ. (1999) Reinforcing effects of psychostimulants in humans are associated with increases in brain dopamine and occupancy of D2 receptors. J Pharm Exp Ther291: 409–415.
56.
WarrenBLIñiguezSDAlcantaraLF. (2011) Juvenile administration of concomitant methylphenidate and fluoxetine alters behavioral reactivity to reward- and mood-related stimuli and disrupts ventral tegmental area gene expression in adulthood. J Neurosci31: 10347–10358.
57.
WestAP (1990) Neurobehavioral studies of forced swimming: The role of learning and memory in the forced swim test. Prog Neuropsychopharmacol Biol Psychiatry14: 863–877.
58.
WheelerTLSmithLNBachusSE. (2013) Low-dose adolescent nicotine and methylphenidate have additive effects on adult behavior and neurochemistry. Pharmacol Biochem Behav103: 723–734.
59.
WootersTENeugebauerNMRushCR. (2008) Methylphenidate enhances the abuse-related behavioral effects of nicotine in rats: Intravenous self-administration, drug discrimination, and locomotor cross-sensitization. Neuropsychopharmacology33: 1137–1148.
